United States · FDA National Drug Code directory
AZELASTINE HYDROCHLORIDE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-020_78ffbb52-56db-49ea-9288-d0d4b263f373
- Product NDC
- 58602-020
- Form
- SPRAY, METERED
- Composition / generic term
- AZELASTINE HYDROCHLORIDE
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20250127
- Source listing expiry
- 20271231
Source-listed ingredients
- AZELASTINE HYDROCHLORIDE — 205.5 ug/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, SPRAY in 1 CARTON (58602-020-07) / 200 SPRAY, METERED in 1 BOTTLE, SPRAY · 58602-020-07
- 1 BOTTLE, SPRAY in 1 CARTON (58602-020-51) / 60 SPRAY, METERED in 1 BOTTLE, SPRAY · 58602-020-51
- 1 BOTTLE, SPRAY in 1 CARTON (58602-020-52) / 120 SPRAY, METERED in 1 BOTTLE, SPRAY · 58602-020-52
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →